Drug intelligence / Profile preview

Jiarong Wan

Development stage: Unknown
Lead developer: Beijing Boran Pharmaceutical
Administration: Oral

Overview

Jiarong Wan (佳蓉丸) is an approved traditional Chinese medicine (TCM) herbal pill developed and manufactured by Beijing Boran Pharmaceutical Co., Ltd. It is administered orally and is part of the company's portfolio of China-SFDA certified pharmaceutical products. As a traditional multi-herb TCM formulation, its specific mechanism of action is not specified, which is characteristic of TCM products where multiple herbal ingredients are intended to work synergistically. The product is commercially available in China for therapeutic indications typical of TCM, such as those related to kidney-yin deficiency and menopausal symptoms, although specific molecular targets or detailed clinical development phases typical of Western pharmaceuticals are not applicable.

Brand names: Jiarong Wan
Other names: 佳蓉丸Jiarong Wan (TCM)

Beyond the preview

Go deeper on Jiarong Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiarong Wan.

Explore the full profile